Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait

Marina Picillo, Raffaele Dubbioso, Rosa Iodice, Alessandro Iavarone, Chiara Pisciotta, Emanuele Spina, Lucio Santoro, Paolo Barone, Marianna Amboni, Fiore Manganelli

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Freezing of gait (FOG) is one of the most common gait disturbances in patients with Parkinson’s disease (PD). Recently, a PET study has documented that PD patients with FOG display cholinergic deficits selectively driven by nucleus basalis of Meynert (nbM)-neocortical denervation and not by peduncolopontine nucleus (PPN)-thalamic degeneration. Short-latency afferent inhibition (SAI) is a neurophysiological technique that allows evaluating major cholinergic sources in the central nervous system in vivo. We sought to determine whether central cholinergic circuits, evaluated by means of SAI testing, are impaired in patients with PD with FOG (FOG+) as compared to those without (FOG−). SAI and neuropsychological data were collected in 14 FOG+ and 10 FOG−. SAI was also performed in 11 healthy control subjects. Demographic, clinical, and cognitive data were compared by using non-parametric tests. Parametric tests were used to compare electrophysiological results among groups. FOG+ and FOG− had similar SAI without significant differences with controls (p = 0.207). None of the PD patients had SAI values outside the normal range (>72 %). FOG+ presented poorer executive and visuospatial performances as compared to FOG−. Despite the presence of cognitive deficits, SAI failed to detect any significant decrease of cholinergic activity in FOG+. However, nbM-related cholinergic dysfunction cannot be ruled out. In fact, integrity or even increased activation of PPN-related cholinergic circuits may mask an eventual nbM dysfunction thus resulting in normal SAI findings. Indeed, selective PPN cholinergic neurons sparing maybe a distinctive features of FOG. Alternatively or complementary, FOG pathophysiology is underpinned by non-cholinergic neurotransmitters dysfunction.

Original languageEnglish
Pages (from-to)1533-1540
Number of pages8
JournalJournal of Neural Transmission
Volume122
Issue number11
DOIs
Publication statusPublished - Jul 31 2015

Fingerprint

Gait
Freezing
Parkinson Disease
Cholinergic Agents
Basal Nucleus of Meynert
Thalamic Nuclei
Cholinergic Neurons
Denervation
Masks
Neurotransmitter Agents
Healthy Volunteers
Reference Values
Central Nervous System

Keywords

  • Cholinergic activity
  • Cognition
  • Freezing
  • Gait
  • Parkinson's disease
  • PPN
  • SAI
  • TMS

ASJC Scopus subject areas

  • Biological Psychiatry
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Picillo, M., Dubbioso, R., Iodice, R., Iavarone, A., Pisciotta, C., Spina, E., ... Manganelli, F. (2015). Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait. Journal of Neural Transmission, 122(11), 1533-1540. https://doi.org/10.1007/s00702-015-1428-y

Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait. / Picillo, Marina; Dubbioso, Raffaele; Iodice, Rosa; Iavarone, Alessandro; Pisciotta, Chiara; Spina, Emanuele; Santoro, Lucio; Barone, Paolo; Amboni, Marianna; Manganelli, Fiore.

In: Journal of Neural Transmission, Vol. 122, No. 11, 31.07.2015, p. 1533-1540.

Research output: Contribution to journalArticle

Picillo, M, Dubbioso, R, Iodice, R, Iavarone, A, Pisciotta, C, Spina, E, Santoro, L, Barone, P, Amboni, M & Manganelli, F 2015, 'Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait', Journal of Neural Transmission, vol. 122, no. 11, pp. 1533-1540. https://doi.org/10.1007/s00702-015-1428-y
Picillo, Marina ; Dubbioso, Raffaele ; Iodice, Rosa ; Iavarone, Alessandro ; Pisciotta, Chiara ; Spina, Emanuele ; Santoro, Lucio ; Barone, Paolo ; Amboni, Marianna ; Manganelli, Fiore. / Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait. In: Journal of Neural Transmission. 2015 ; Vol. 122, No. 11. pp. 1533-1540.
@article{e31af3cbbf174db9906ab9241fe66691,
title = "Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait",
abstract = "Freezing of gait (FOG) is one of the most common gait disturbances in patients with Parkinson’s disease (PD). Recently, a PET study has documented that PD patients with FOG display cholinergic deficits selectively driven by nucleus basalis of Meynert (nbM)-neocortical denervation and not by peduncolopontine nucleus (PPN)-thalamic degeneration. Short-latency afferent inhibition (SAI) is a neurophysiological technique that allows evaluating major cholinergic sources in the central nervous system in vivo. We sought to determine whether central cholinergic circuits, evaluated by means of SAI testing, are impaired in patients with PD with FOG (FOG+) as compared to those without (FOG−). SAI and neuropsychological data were collected in 14 FOG+ and 10 FOG−. SAI was also performed in 11 healthy control subjects. Demographic, clinical, and cognitive data were compared by using non-parametric tests. Parametric tests were used to compare electrophysiological results among groups. FOG+ and FOG− had similar SAI without significant differences with controls (p = 0.207). None of the PD patients had SAI values outside the normal range (>72 {\%}). FOG+ presented poorer executive and visuospatial performances as compared to FOG−. Despite the presence of cognitive deficits, SAI failed to detect any significant decrease of cholinergic activity in FOG+. However, nbM-related cholinergic dysfunction cannot be ruled out. In fact, integrity or even increased activation of PPN-related cholinergic circuits may mask an eventual nbM dysfunction thus resulting in normal SAI findings. Indeed, selective PPN cholinergic neurons sparing maybe a distinctive features of FOG. Alternatively or complementary, FOG pathophysiology is underpinned by non-cholinergic neurotransmitters dysfunction.",
keywords = "Cholinergic activity, Cognition, Freezing, Gait, Parkinson's disease, PPN, SAI, TMS",
author = "Marina Picillo and Raffaele Dubbioso and Rosa Iodice and Alessandro Iavarone and Chiara Pisciotta and Emanuele Spina and Lucio Santoro and Paolo Barone and Marianna Amboni and Fiore Manganelli",
year = "2015",
month = "7",
day = "31",
doi = "10.1007/s00702-015-1428-y",
language = "English",
volume = "122",
pages = "1533--1540",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer-Verlag Wien",
number = "11",

}

TY - JOUR

T1 - Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait

AU - Picillo, Marina

AU - Dubbioso, Raffaele

AU - Iodice, Rosa

AU - Iavarone, Alessandro

AU - Pisciotta, Chiara

AU - Spina, Emanuele

AU - Santoro, Lucio

AU - Barone, Paolo

AU - Amboni, Marianna

AU - Manganelli, Fiore

PY - 2015/7/31

Y1 - 2015/7/31

N2 - Freezing of gait (FOG) is one of the most common gait disturbances in patients with Parkinson’s disease (PD). Recently, a PET study has documented that PD patients with FOG display cholinergic deficits selectively driven by nucleus basalis of Meynert (nbM)-neocortical denervation and not by peduncolopontine nucleus (PPN)-thalamic degeneration. Short-latency afferent inhibition (SAI) is a neurophysiological technique that allows evaluating major cholinergic sources in the central nervous system in vivo. We sought to determine whether central cholinergic circuits, evaluated by means of SAI testing, are impaired in patients with PD with FOG (FOG+) as compared to those without (FOG−). SAI and neuropsychological data were collected in 14 FOG+ and 10 FOG−. SAI was also performed in 11 healthy control subjects. Demographic, clinical, and cognitive data were compared by using non-parametric tests. Parametric tests were used to compare electrophysiological results among groups. FOG+ and FOG− had similar SAI without significant differences with controls (p = 0.207). None of the PD patients had SAI values outside the normal range (>72 %). FOG+ presented poorer executive and visuospatial performances as compared to FOG−. Despite the presence of cognitive deficits, SAI failed to detect any significant decrease of cholinergic activity in FOG+. However, nbM-related cholinergic dysfunction cannot be ruled out. In fact, integrity or even increased activation of PPN-related cholinergic circuits may mask an eventual nbM dysfunction thus resulting in normal SAI findings. Indeed, selective PPN cholinergic neurons sparing maybe a distinctive features of FOG. Alternatively or complementary, FOG pathophysiology is underpinned by non-cholinergic neurotransmitters dysfunction.

AB - Freezing of gait (FOG) is one of the most common gait disturbances in patients with Parkinson’s disease (PD). Recently, a PET study has documented that PD patients with FOG display cholinergic deficits selectively driven by nucleus basalis of Meynert (nbM)-neocortical denervation and not by peduncolopontine nucleus (PPN)-thalamic degeneration. Short-latency afferent inhibition (SAI) is a neurophysiological technique that allows evaluating major cholinergic sources in the central nervous system in vivo. We sought to determine whether central cholinergic circuits, evaluated by means of SAI testing, are impaired in patients with PD with FOG (FOG+) as compared to those without (FOG−). SAI and neuropsychological data were collected in 14 FOG+ and 10 FOG−. SAI was also performed in 11 healthy control subjects. Demographic, clinical, and cognitive data were compared by using non-parametric tests. Parametric tests were used to compare electrophysiological results among groups. FOG+ and FOG− had similar SAI without significant differences with controls (p = 0.207). None of the PD patients had SAI values outside the normal range (>72 %). FOG+ presented poorer executive and visuospatial performances as compared to FOG−. Despite the presence of cognitive deficits, SAI failed to detect any significant decrease of cholinergic activity in FOG+. However, nbM-related cholinergic dysfunction cannot be ruled out. In fact, integrity or even increased activation of PPN-related cholinergic circuits may mask an eventual nbM dysfunction thus resulting in normal SAI findings. Indeed, selective PPN cholinergic neurons sparing maybe a distinctive features of FOG. Alternatively or complementary, FOG pathophysiology is underpinned by non-cholinergic neurotransmitters dysfunction.

KW - Cholinergic activity

KW - Cognition

KW - Freezing

KW - Gait

KW - Parkinson's disease

KW - PPN

KW - SAI

KW - TMS

UR - http://www.scopus.com/inward/record.url?scp=84945445961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945445961&partnerID=8YFLogxK

U2 - 10.1007/s00702-015-1428-y

DO - 10.1007/s00702-015-1428-y

M3 - Article

VL - 122

SP - 1533

EP - 1540

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 11

ER -